- Home
- IMA vs MAIA Comparison
IMA vs MAIA Comparison
Compare IMA & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMA
- MAIA
- Stock Information
- Founded
- IMA 2019
- MAIA 2018
- Country
- IMA United States
- MAIA United States
- Employees
- IMA N/A
- MAIA N/A
- Industry
- IMA Biotechnology: Biological Products (No Diagnostic Substances)
- MAIA Biotechnology: Pharmaceutical Preparations
- Sector
- IMA Health Care
- MAIA Health Care
- Exchange
- IMA Nasdaq
- MAIA Nasdaq
- Market Cap
- IMA 69.5M
- MAIA 56.3M
- IPO Year
- IMA N/A
- MAIA 2022
- Fundamental
- Price
- IMA N/A
- MAIA $1.52
- Analyst Decision
- IMA
- MAIA
- Analyst Count
- IMA 0
- MAIA 0
- Target Price
- IMA N/A
- MAIA N/A
- AVG Volume (30 Days)
- IMA 45.7K
- MAIA 539.4K
- Earning Date
- IMA 01-01-0001
- MAIA 08-12-2025
- Dividend Yield
- IMA N/A
- MAIA N/A
- EPS Growth
- IMA N/A
- MAIA N/A
- EPS
- IMA N/A
- MAIA N/A
- Revenue
- IMA N/A
- MAIA N/A
- Revenue This Year
- IMA N/A
- MAIA N/A
- Revenue Next Year
- IMA N/A
- MAIA N/A
- P/E Ratio
- IMA N/A
- MAIA N/A
- Revenue Growth
- IMA N/A
- MAIA N/A
- 52 Week Low
- IMA $11.65
- MAIA $1.40
- 52 Week High
- IMA $23.28
- MAIA $3.74
- Technical
- Relative Strength Index (RSI)
- IMA N/A
- MAIA 34.15
- Support Level
- IMA N/A
- MAIA $1.68
- Resistance Level
- IMA N/A
- MAIA $1.89
- Average True Range (ATR)
- IMA 0.00
- MAIA 0.09
- MACD
- IMA 0.00
- MAIA -0.02
- Stochastic Oscillator
- IMA 0.00
- MAIA 11.63
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.